Biogen, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US09062X1037
  • NASDAQ: BIIB
USD
225.36
6.29 (2.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryBiogen, Inc. VS Pharmaceuticals & Biotechnology
 
1D
2.87%
-0.75%
1W
4.25%
2.04%
1M
3.96%
0.41%
YTD
28.05%
12.57%
1Y
60.22%
15.76%
3Y
-12.54%
78.38%
5Y
-22.11%
73.21%
10Y
-22.28%
255.99%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.84%
0%
12.84%
6 Months
24.19%
0%
24.19%
1 Year
60.22%
0%
60.22%
2 Years
13.04%
0%
13.04%
3 Years
-12.54%
0%
-12.54%
4 Years
12.33%
0%
12.33%
5 Years
-22.11%
0%
-22.11%

Biogen, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Footer loading